FindTrial
Sign In

Prevalence of Body Dysmorphic Disorder in topical steroid damaged face (TSDF) patients

Study of Body dysmorphic disorder and psychiatric co-morbidities in patients of topical steroid damaged face attending Dermatology OPD in a tertiary care center: Hospital based study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/068101
Enrollment
185
Registered
2024-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L54- Erythema in diseases classified elsewhere

Interventions

Intervention1: NIL: NIL

Sponsors

Shri Ram Murti Institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged above18 years attending Dermatology OPD. 2. Patients willing to give written informed consent. 3. Patients able to fill the English questionnaires.

Exclusion criteria

Exclusion criteria: 1. Patients refusing to participate in the study. 2. Patients who can’t fill English questionnaire.

Design outcomes

Primary

MeasureTime frame
To assess prevalence of body dysmorphic disorder in TSDF patientsTimepoint: 9 Months—

Secondary

MeasureTime frame
- To assess comorbid psychiatric illness in the identified BDD patients. - To determine their sociodemographic & clinical correlates. Timepoint: 9 months—

Countries

India

Contacts

Public ContactDr Pratik Gahalaut

Shri Ram Murti Institute of Medical sciences

kantmadhur@gmail.com9319758004

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026